Cite Filings / HRTX / 0000902664-25-003536

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

HERON THERAPEUTICS, INC. /DE/ Filed 2025-08-12 Acc 0000902664-25-003536

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-10-17 SCHEDULE 13D/A Beneficial Ownership Report
2025-08-15 8-A12B Registration of Securities
2025-08-12 8-K Material agreement · Bylaws or fiscal year change · Other events
2025-08-12 8-K Material agreement
2025-08-12 4 Director bought 1,766,546 shares at $1.50 ($2,649,819)
2025-08-12 SCHEDULE 13D/A Beneficial Ownership Report
2025-08-12 4 10% owner bought 2,387,225 shares at $1.50 ($3,580,838)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…